--- title: "Alpha-Ketoglutarate (AKG) Side Effects: Complete 2026 Safety" url: https://www.bodyhackguide.co/side-effects/alpha-ketoglutarate-akg description: "Alpha-Ketoglutarate (AKG) side effects, contraindications, severity tiers, and how to minimize adverse reactions. Evidence-based safety guide updated 2026." lang: en --- Skip to content Compare notes on r/BodyHackGuide (https://reddit.com/r/bodyhackguide) Compare notes with other researchers. Join r/BodyHackGuide (https://reddit.com/r/bodyhackguide) 2026 Safety Guide # Alpha-Ketoglutarate (AKG) Side Effects Complete Alpha-Ketoglutarate (AKG) safety profile: reported side effects from published research, contraindications, severity tiers, and how to minimize adverse reactions through proper dosing and vendor selection. ## Reported Alpha-Ketoglutarate (AKG) side effects What human studies recorded In a randomized crossover trial in hemodialysis patients in Copenhagen, 5 of 17 patients stopped calcium ketoglutarate within 1 to 2 weeks because of vomiting, anorexia, diarrhea or general uneasiness; all 5 had stomach or bowel symptoms before the study, and the other 12 reported no side effects (PMID: 9469496). Plasma ionized calcium was lower on calcium ketoglutarate than on calcium carbonate in that trial (PMID: 9469496). In a crossover trial in 28 hemodialysis patients, high blood calcium occurred in 1 patient on calcium ketoglutarate and 8 on calcium acetate (PMID: 10383011). In 20 patients after major abdominal surgery, tube feeding enriched with AKG lowered serum albumin more than standard feeding and did not improve nitrogen balance or clinical outcomes (PMID: 12297206). The longest human study found lasted 36 months, in 14 hemodialysis patients given calcium AKG as a phosphate binder, in whom serum phosphate and parathyroid hormone fell and serum calcium rose (PMID: 8676818). Animal data In the 2020 Buck Institute study, the authors did not detect significant adverse changes in mice fed 2 percent Ca-AKG from 18 months of age (PMID: 32877690). In the Interventions Testing Program's 2022 cohort, median lifespan with AKG differed from controls by +3.4 percent in males and -1.6 percent in females, neither statistically significant (PMID: 41843349). Gaps No human data on AKG supplements in pregnancy or breastfeeding were found, and no human pharmacokinetic or drug interaction studies of oral AKG supplements were found. ## When to continue, reduce, or stop Alpha-Ketoglutarate (AKG) Mild: continue protocol Transient mild symptoms (slight GI upset, minor injection-site reaction, brief fatigue) typically resolve within 3-7 days as physiology adjusts. Continue at current dose; monitor weekly. Moderate: reduce dose Persistent mild symptoms past two weeks, or new symptoms like sustained mood changes, sleep disruption, or appetite shifts. Reduce dose by 25-50% and reassess at the end of the next 2-week window. Severe: discontinue + seek care Any signal of allergic response (rash, swelling, breathing difficulty), unexplained chest discomfort, severe injection-site reaction with infection signs, or vision changes. Discontinue immediately and consult a licensed practitioner. ## Alpha-Ketoglutarate (AKG) contraindications In a dialysis trial, the patients who could not tolerate calcium ketoglutarate all had gastrointestinal symptoms before starting (PMID: 9469496). In dialysis patients, calcium ketoglutarate lowered serum phosphate as other calcium phosphate binders do and changed blood calcium and amino acid levels (PMID: 10383011, PMID: 9469496, PMID: 8676801), so the salt is not metabolically neutral when the kidneys fail. No human data were found for pregnancy or breastfeeding. ## Why vendor quality drives Alpha-Ketoglutarate (AKG) side-effect frequency Research-compound communities consistently report that adverse-event frequency tracks with source quality. Three reasons: (1) impurity profiles vary by lab (residual synthesis byproducts can trigger reactions); (2) mislabeled mass means actual dose can be 50-150% of stated dose; (3) reconstitution-grade water and capping methodology affect long-term storage stability. COA-verified vendors with published HPLC data minimize all three failure modes. Check a vendor's COA record and Trust Score before you buy. Full Alpha-Ketoglutarate (AKG) profile Mechanism, dosing, half-life, peer-reviewed studies. https://www.bodyhackguide.co/compound/alpha-ketoglutarate-akg Alpha-Ketoglutarate (AKG) protocol Three-tier dosing protocol with cycle structure. https://www.bodyhackguide.co/protocol/alpha-ketoglutarate-akg Alternatives If side-effect profile rules out Alpha-Ketoglutarate (AKG) for you, similar compounds. https://www.bodyhackguide.co/alternatives-to/alpha-ketoglutarate-akg ## Alpha-Ketoglutarate (AKG) side effects FAQ ### What are the most common Alpha-Ketoglutarate (AKG) side effects? What human studies recorded In a randomized crossover trial in hemodialysis patients in Copenhagen, 5 of 17 patients stopped calcium ketoglutarate within 1 to 2 weeks because of vomiting, anorexia, diarrhea or general uneasiness; all 5 had stomach or bowel symptoms before the study, and the other 12 reported no side effects (PMID: 9469496). Plasma ionized calcium was lower on calcium ketoglutarate ### Are there severe side effects to watch for with Alpha-Ketoglutarate (AKG)? Severe reactions are rare in published research but can occur. Watch for: allergic-type symptoms (rash, swelling, breathing difficulty), unexplained chest discomfort, infection signs at injection sites, vision changes, or severe persistent mood/sleep disruption. Any of these warrants immediate discontinuation and consultation with a licensed practitioner. The Severity Tiers section above triages mild → moderate → severe response patterns. ### Does Alpha-Ketoglutarate (AKG) have contraindications? In a dialysis trial, the patients who could not tolerate calcium ketoglutarate all had gastrointestinal symptoms before starting (PMID: 9469496). In dialysis patients, calcium ketoglutarate lowered serum phosphate as other calcium phosphate binders do and changed blood calcium and amino acid levels (PMID: 10383011, PMID: 9469496, PMID: 8676801), so the salt is not metabolically neutral when the ki ### How can I minimize Alpha-Ketoglutarate (AKG) side effects? Three biggest levers: (1) Start at the Beginner-tier dose for 2-3 weeks before escalating, which gives time to detect adverse signals at minimum effective dose. (2) Source from COA-verified vendors only: impurity profiles and mislabeled compounds drive a disproportionate share of reported side effects in research-compound communities. (3) Maintain adequate cycle off-time when applicable: receptor-saturating compounds benefit from 4-6 week breaks. The vendor section below lists the cheapest in-stock Alpha-Ketoglutarate (AKG) sources we track, each linked to its Trust Score (COA verification is 30% of the score). **Research-use disclaimer.** All safety information on this page summarizes published research literature and community-reported reactions. It is not medical advice and not authorization for human consumption. Always consult a licensed practitioner before any compound enters a clinical context. Compounds linked from this page are sold for research-use only. **Affiliate disclosure.** See our affiliate disclosure (https://www.bodyhackguide.co/affiliate-disclosure). Free 2026 Peptide Cheat Sheet (PDF) 38 compounds and blends: vial sizes, BAC water volumes, dosing ranges and bloodwork markers. Download Free (https://www.bodyhackguide.co/guides/peptide-cheat-sheet-download) BodyHackGuide (https://www.bodyhackguide.co/) Your biohacking research hub: compound pricing, brain health protocols, dosing tools, and vendor reviews. support@bodyhackguide.co Join our Discord: https://discord.gg/Mhq5UdRYBA r/BodyHackGuide on Reddit: https://reddit.com/r/BodyHackGuide **Affiliate Disclosure:** We rank every vendor on the same public, reproducible methodology (https://www.bodyhackguide.co/vendors/methodology). Full details in our affiliate disclosure (https://www.bodyhackguide.co/affiliate-disclosure). **Research Disclaimer:** All compounds listed are for laboratory and research purposes only. Not for human consumption. This site does not sell or ship any products. Always consult a qualified healthcare professional and comply with local regulations. © 2026 BodyHackGuide. All rights reserved. - Terms: https://www.bodyhackguide.co/terms - Privacy: https://www.bodyhackguide.co/privacy ## Structured data ```json [ { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.bodyhackguide.co/" }, { "@type": "ListItem", "position": 2, "name": "Compare", "item": "https://www.bodyhackguide.co/compare" }, { "@type": "ListItem", "position": 3, "name": "Alpha-Ketoglutarate (AKG) Side Effects" } ] }, { "@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.bodyhackguide.co" }, { "@type": "ListItem", "position": 2, "name": "Compare", "item": "https://www.bodyhackguide.co/compare" }, { "@type": "ListItem", "position": 3, "name": "Alpha-Ketoglutarate (AKG) Side Effects", "item": "https://www.bodyhackguide.co/side-effects/alpha-ketoglutarate-akg" } ] }, { "@context": "https://schema.org", "@type": "Drug", "name": "Alpha-Ketoglutarate (AKG)", "description": "Research compound. Safety profile, side effects, and contraindications summary.", "availableStrength": { "@type": "DrugStrength", "strengthValue": "" }, "contraindication": "In a dialysis trial, the patients who could not tolerate calcium ketoglutarate all had gastrointestinal symptoms before starting (PMID: 9469496). In dialysis patients, calcium ketoglutarate lowered serum phosphate as other calcium phosphate binders do and changed blood calcium and amino acid levels " }, { "@context": "https://schema.org", "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "What are the most common Alpha-Ketoglutarate (AKG) side effects?", "acceptedAnswer": { "@type": "Answer", "text": "What human studies recorded In a randomized crossover trial in hemodialysis patients in Copenhagen, 5 of 17 patients stopped calcium ketoglutarate within 1 to 2 weeks because of vomiting, anorexia, diarrhea or general uneasiness; all 5 had stomach or bowel symptoms before the study, and the other 12 reported no side effects (PMID: 9469496). Plasma ionized calcium was lower on calcium ketoglutarate" } }, { "@type": "Question", "name": "Are there severe side effects to watch for with Alpha-Ketoglutarate (AKG)?", "acceptedAnswer": { "@type": "Answer", "text": "Severe reactions are rare in published research but can occur. Watch for: allergic-type symptoms (rash, swelling, breathing difficulty), unexplained chest discomfort, infection signs at injection sites, vision changes, or severe persistent mood/sleep disruption. Any of these warrants immediate discontinuation and consultation with a licensed practitioner. The Severity Tiers section above triages mild → moderate → severe response patterns." } }, { "@type": "Question", "name": "Does Alpha-Ketoglutarate (AKG) have contraindications?", "acceptedAnswer": { "@type": "Answer", "text": "In a dialysis trial, the patients who could not tolerate calcium ketoglutarate all had gastrointestinal symptoms before starting (PMID: 9469496). In dialysis patients, calcium ketoglutarate lowered serum phosphate as other calcium phosphate binders do and changed blood calcium and amino acid levels (PMID: 10383011, PMID: 9469496, PMID: 8676801), so the salt is not metabolically neutral when the ki" } }, { "@type": "Question", "name": "How can I minimize Alpha-Ketoglutarate (AKG) side effects?", "acceptedAnswer": { "@type": "Answer", "text": "Three biggest levers: (1) Start at the Beginner-tier dose for 2-3 weeks before escalating, which gives time to detect adverse signals at minimum effective dose. (2) Source from COA-verified vendors only: impurity profiles and mislabeled compounds drive a disproportionate share of reported side effects in research-compound communities. (3) Maintain adequate cycle off-time when applicable: receptor-saturating compounds benefit from 4-6 week breaks. The vendor section below lists the cheapest in-stock Alpha-Ketoglutarate (AKG) sources we track, each linked to its Trust Score (COA verification is 30% of the score)." } } ] } ] ```